DK1620085T3 - Anvendelse af phenoxyacetatsyrederivater til behandling af hyperaktiv blære - Google Patents

Anvendelse af phenoxyacetatsyrederivater til behandling af hyperaktiv blære

Info

Publication number
DK1620085T3
DK1620085T3 DK04722967T DK04722967T DK1620085T3 DK 1620085 T3 DK1620085 T3 DK 1620085T3 DK 04722967 T DK04722967 T DK 04722967T DK 04722967 T DK04722967 T DK 04722967T DK 1620085 T3 DK1620085 T3 DK 1620085T3
Authority
DK
Denmark
Prior art keywords
phenoxyacetate
treatment
acid derivatives
hyperactive bladder
hyperactive
Prior art date
Application number
DK04722967T
Other languages
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1620085(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of DK1620085T3 publication Critical patent/DK1620085T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK04722967T 2003-05-05 2004-03-24 Anvendelse af phenoxyacetatsyrederivater til behandling af hyperaktiv blære DK1620085T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
PCT/JP2004/004048 WO2004098586A1 (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Publications (1)

Publication Number Publication Date
DK1620085T3 true DK1620085T3 (da) 2008-11-24

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04722967T DK1620085T3 (da) 2003-05-05 2004-03-24 Anvendelse af phenoxyacetatsyrederivater til behandling af hyperaktiv blære

Country Status (26)

Country Link
US (1) US20040229947A1 (da)
EP (1) EP1620085B1 (da)
JP (1) JP4602969B2 (da)
KR (1) KR101052804B1 (da)
AR (1) AR044169A1 (da)
AT (1) ATE401878T1 (da)
AU (1) AU2004236596B2 (da)
BR (1) BRPI0409980A (da)
CA (1) CA2524023C (da)
CL (1) CL2004000952A1 (da)
CY (1) CY1108425T1 (da)
DE (1) DE602004015272D1 (da)
DK (1) DK1620085T3 (da)
ES (1) ES2309513T3 (da)
IL (1) IL171713A (da)
MX (1) MXPA05011862A (da)
MY (1) MY141756A (da)
NZ (1) NZ543347A (da)
PE (1) PE20050524A1 (da)
PL (1) PL1620085T3 (da)
PT (1) PT1620085E (da)
RU (1) RU2342133C2 (da)
SI (1) SI1620085T1 (da)
TW (1) TWI351279B (da)
UY (1) UY28306A1 (da)
WO (1) WO2004098586A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
CA2605298A1 (en) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
US7763654B2 (en) * 2005-04-26 2010-07-27 Kissei Pharmaceutical Co., Ltd. Crystal polymorph of hydroxynorephedrin derivative hydrochloride
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
EP4410295A3 (en) 2017-06-06 2024-10-16 Urovant Sciences GmbH Use of vibegron to treat overactive bladder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
US6410484B1 (en) * 1999-11-01 2002-06-25 Sumitomo Chemical Company, Limited 6-Hydroxy-5,6-dihydrouracil compound and herbicidal composition containing thereof
MXPA04002449A (es) * 2001-09-13 2004-07-23 Kissei Pharmaceutical Cristales de derivado de hidroxinorefedrina.

Also Published As

Publication number Publication date
ES2309513T3 (es) 2008-12-16
EP1620085A1 (en) 2006-02-01
CA2524023C (en) 2011-11-22
EP1620085B1 (en) 2008-07-23
CY1108425T1 (el) 2014-04-09
JP4602969B2 (ja) 2010-12-22
KR101052804B1 (ko) 2011-07-29
IL171713A (en) 2011-12-29
JP2006525318A (ja) 2006-11-09
CA2524023A1 (en) 2004-11-18
US20040229947A1 (en) 2004-11-18
PE20050524A1 (es) 2005-07-07
CL2004000952A1 (es) 2005-03-04
WO2004098586A1 (en) 2004-11-18
PT1620085E (pt) 2008-08-07
ATE401878T1 (de) 2008-08-15
AU2004236596B2 (en) 2010-03-11
SI1620085T1 (sl) 2008-12-31
AR044169A1 (es) 2005-08-24
RU2005137701A (ru) 2006-06-10
UY28306A1 (es) 2004-12-31
KR20060009886A (ko) 2006-02-01
MXPA05011862A (es) 2006-02-17
MY141756A (en) 2010-06-30
NZ543347A (en) 2008-05-30
RU2342133C2 (ru) 2008-12-27
DE602004015272D1 (de) 2008-09-04
TW200509902A (en) 2005-03-16
PL1620085T3 (pl) 2009-01-30
BRPI0409980A (pt) 2006-05-09
TWI351279B (en) 2011-11-01
AU2004236596A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1830843T3 (da) Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DK1706112T3 (da) Fremgangsmåder til at behandle en inflammatorisk-beslægtet sygdom
DK1585749T3 (da) Diazepinoindol-derivater som kinaseinhibitorer
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
IS8275A (is) Píperasín afleiður til meðhöndlunar á HIV sýkingum
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
DK1708991T3 (da) Sulfonamid derivater til behandling af sygdomme
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DE602004011548D1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
DK1516540T3 (da) Anvendelse af vitamin D-forbindelser
DK1828151T3 (da) Malonamidderivater som inhibitorer af gamma-sekretase til behandlingen af alzheimer's sygdom
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DK1856063T3 (da) 5-phenyl-pentansyrederivater som matrix- metalloproteinaseinhibitorer til behandlingen af astma og andre sygdomme
DK1620085T3 (da) Anvendelse af phenoxyacetatsyrederivater til behandling af hyperaktiv blære
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1567524T3 (da) Thia-epothilonderivater til behandling af cancer
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi